Central alpha-2 Adrenergic Agonist [EPC]

Central alpha-2 Adrenergic Agonist [EPC] was reported 53980 times

Drugs of the Central alpha-2 Adrenergic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 WITHDRAWAL HYPERTENSION 56 0.2772
1 DEVICE WIRELESS COMMUNICATION ISSUE 67 0.2587
2 NEOVASCULARISATION 60 0.2281
3 VICTIM OF CHILD ABUSE 49 0.1952
4 TEMPERATURE REGULATION DISORDER 430 0.1928
5 DEVICE MAINTENANCE ISSUE 100 0.1701
6 CHILD ABUSE 42 0.1622
7 EPIDURAL LIPOMATOSIS 54 0.1570
8 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 147 0.1384
9 OPPOSITIONAL DEFIANT DISORDER 50 0.1266
10 NEPHROGENIC ANAEMIA 564 0.1216
11 HYPERPARATHYROIDISM SECONDARY 296 0.1180
12 BODY TINEA 55 0.0982
13 INFUSION SITE DISCHARGE 156 0.0889
14 INFUSION SITE IRRITATION 107 0.0833
15 INFUSION SITE INDURATION 117 0.0789
16 INFUSION SITE NODULE 74 0.0770
17 DEVICE INFUSION ISSUE 184 0.0741
18 INFUSION SITE HAEMORRHAGE 242 0.0735
19 INFUSION SITE WARMTH 87 0.0710
20 FOOD ALLERGY 548 0.0709
21 INFUSION SITE INFECTION 162 0.0696
22 INFUSION SITE INFLAMMATION 48 0.0680
23 INFUSION SITE DISCOLOURATION 58 0.0659
24 INFUSION SITE PAIN 845 0.0655
25 INFUSION SITE ERYTHEMA 530 0.0628
26 IMPLANT SITE EXTRAVASATION 49 0.0623
27 END STAGE RENAL DISEASE 1124 0.0616
28 INFUSION SITE MASS 66 0.0607
29 INFUSION SITE SWELLING 374 0.0594
30 REBOUND ACID HYPERSECRETION 174 0.0575
31 CHOREOATHETOSIS 39 0.0574
32 FOETAL DEATH 259 0.0499
33 MALIGNANT HYPERTENSION 42 0.0489
34 NEPHROGENIC SYSTEMIC FIBROSIS 141 0.0466
35 HYPERTENSIVE EMERGENCY 53 0.0450
36 INFUSION SITE REACTION 130 0.0435
37 INFUSION SITE DISCOMFORT 45 0.0434
38 BLOOD PRESSURE INADEQUATELY CONTROLLED 254 0.0422
39 COELIAC DISEASE 411 0.0419
40 INFUSION SITE PRURITUS 123 0.0389
41 IMMUNODEFICIENCY 574 0.0385
42 SUSPECTED SUICIDE 178 0.0379
43 INHIBITORY DRUG INTERACTION 60 0.0379
44 BURSITIS 427 0.0352
45 DEVICE ALARM ISSUE 63 0.0347
46 INFUSION SITE RASH 45 0.0328
47 SKIN INDURATION 68 0.0328
48 DEVICE POWER SOURCE ISSUE 88 0.0301
49 PARADOXICAL DRUG REACTION 109 0.0296
50 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 73 0.0295
51 CHRONIC KIDNEY DISEASE 2120 0.0279
52 INFECTION SUSCEPTIBILITY INCREASED 59 0.0269
53 INFUSION SITE BRUISING 58 0.0268
54 LEFT VENTRICULAR HYPERTROPHY 114 0.0266
55 PRESCRIBED OVERDOSE 498 0.0257
56 APPLICATION SITE PRURITUS 569 0.0251
57 DEVICE CONNECTION ISSUE 49 0.0232
58 SKIN HYPERTROPHY 65 0.0231
59 APPLICATION SITE RASH 317 0.0230
60 HYPERTENSIVE CRISIS 255 0.0229
61 JUVENILE IDIOPATHIC ARTHRITIS 56 0.0229
62 DISTRIBUTIVE SHOCK 51 0.0225
63 SINUS BRADYCARDIA 217 0.0224
64 RESPIRATORY DEPRESSION 274 0.0223
65 RENAL INJURY 645 0.0217
66 HYPERTENSIVE HEART DISEASE 40 0.0214
67 HOMICIDAL IDEATION 84 0.0207
68 APPLICATION SITE ERYTHEMA 538 0.0205
69 RENAL FAILURE CHRONIC 157 0.0204
70 KIDNEY TRANSPLANT REJECTION 96 0.0200
71 PURULENT DISCHARGE 84 0.0196
72 APPLICATION SITE BURN 96 0.0195
73 TIC 105 0.0192
74 PRODUCT ADHESION ISSUE 663 0.0185
75 APPLICATION SITE VESICLES 120 0.0185
76 OBESITY 293 0.0184
77 APLASTIC ANAEMIA 95 0.0182
78 APPLICATION SITE URTICARIA 40 0.0178
79 IMPLANT SITE INFECTION 41 0.0176
80 FIBROSIS 53 0.0172
81 NEPHROPATHY 155 0.0166
82 APPLICATION SITE IRRITATION 205 0.0165
83 SEDATION COMPLICATION 42 0.0164
84 HYPOVENTILATION 53 0.0162
85 RENAL TUBULAR NECROSIS 158 0.0161
86 COMPLETED SUICIDE 1337 0.0160
87 MENTAL STATUS CHANGES 428 0.0154
88 GLUCOSE TOLERANCE IMPAIRED 90 0.0152
89 AUTONOMIC NERVOUS SYSTEM IMBALANCE 44 0.0150
90 HYPERLIPIDAEMIA 180 0.0150
91 CATATONIA 79 0.0150
92 DERMATITIS CONTACT 171 0.0150
93 RENAL TRANSPLANT 54 0.0149
94 SEDATION 386 0.0147
95 UPPER RESPIRATORY TRACT INFECTION 680 0.0147
96 FLUID RETENTION 748 0.0147
97 IMPULSIVE BEHAVIOUR 55 0.0146
98 PSYCHOMOTOR HYPERACTIVITY 243 0.0146
99 DRUG TOLERANCE 74 0.0146
100 RENAL FAILURE 1935 0.0146
101 BRADYCARDIA 771 0.0145
102 BLOOD PROLACTIN INCREASED 68 0.0144
103 HYPERAESTHESIA 118 0.0143
104 DIABETIC NEUROPATHY 70 0.0141
105 HYPERREFLEXIA 49 0.0141
106 ATRIOVENTRICULAR BLOCK FIRST DEGREE 60 0.0138
107 MULTIPLE DRUG OVERDOSE 67 0.0135
108 HYPERTENSION 2856 0.0135
109 MIOSIS 108 0.0134
110 DEVICE FAILURE 198 0.0130
111 IMPLANT SITE PAIN 58 0.0130
112 ECONOMIC PROBLEM 196 0.0129
113 DIABETIC RETINOPATHY 43 0.0126
114 OVERWEIGHT 68 0.0126
115 BLOOD PRESSURE INCREASED 1922 0.0126
116 APPLICATION SITE DISCOLOURATION 51 0.0125
117 SKIN TIGHTNESS 59 0.0125
118 BUNDLE BRANCH BLOCK LEFT 53 0.0125
119 RASH ERYTHEMATOUS 596 0.0125
120 TUBULOINTERSTITIAL NEPHRITIS 233 0.0124
121 CONTRAINDICATED PRODUCT ADMINISTERED 375 0.0124
122 HYPERVOLAEMIA 61 0.0123
123 ACUTE KIDNEY INJURY 1865 0.0122
124 INTERVERTEBRAL DISC DISORDER 52 0.0122
125 BEHAVIOUR DISORDER 65 0.0120
126 ANURIA 102 0.0118
127 AGGRESSION 592 0.0118
128 DEVICE KINK 43 0.0118
129 PULSELESS ELECTRICAL ACTIVITY 48 0.0115
130 NEUROLEPTIC MALIGNANT SYNDROME 136 0.0115
131 POISONING 144 0.0115
132 DEVICE OCCLUSION 161 0.0114
133 BLOOD PRESSURE FLUCTUATION 272 0.0113
134 KLEBSIELLA INFECTION 57 0.0113
135 TRISMUS 58 0.0112
136 SPRUE-LIKE ENTEROPATHY 55 0.0111
137 OESOPHAGEAL PAIN 44 0.0111
138 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 57 0.0111
139 APPLICATION SITE SWELLING 55 0.0110
140 HAEMOGLOBIN INCREASED 49 0.0107
141 ANHEDONIA 282 0.0107
142 CARDIOMEGALY 132 0.0107
143 RENAL CYST 85 0.0107
144 APNOEA 83 0.0107
145 BRUXISM 57 0.0106
146 ALCOHOLISM 45 0.0105
147 HEPATIC ENZYME INCREASED 713 0.0104
148 WITHDRAWAL SYNDROME 438 0.0104
149 DRUG SCREEN POSITIVE 82 0.0104
150 SLEEP APNOEA SYNDROME 198 0.0104
151 HYPERCHOLESTEROLAEMIA 100 0.0103
152 ABDOMINAL TENDERNESS 51 0.0103
153 POOR QUALITY SLEEP 221 0.0103
154 PROCTALGIA 66 0.0103
155 DROOLING 70 0.0101
156 MONOPLEGIA 44 0.0101
157 HYPERHIDROSIS 1303 0.0101
158 ARTERIOSCLEROSIS 95 0.0101
159 SUPRAVENTRICULAR TACHYCARDIA 95 0.0099
160 HYPOVOLAEMIA 58 0.0099
161 TENDERNESS 103 0.0099
162 TOXIC EPIDERMAL NECROLYSIS 149 0.0098
163 CARDIAC FAILURE CONGESTIVE 788 0.0098
164 JOINT RANGE OF MOTION DECREASED 131 0.0098
165 UNRESPONSIVE TO STIMULI 252 0.0098
166 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 66 0.0097
167 IMPAIRED GASTRIC EMPTYING 132 0.0097
168 HYPOTONIA 96 0.0096
169 HAEMORRHAGIC ANAEMIA 42 0.0095
170 POST-TRAUMATIC STRESS DISORDER 64 0.0095
171 CORONARY ARTERY DISEASE 288 0.0095
172 SCREAMING 60 0.0094
173 ESCHERICHIA URINARY TRACT INFECTION 40 0.0094
174 ENURESIS 38 0.0094
175 IMPAIRED QUALITY OF LIFE 135 0.0094
176 CARDIO-RESPIRATORY ARREST 390 0.0093
177 RESPIRATORY ARREST 257 0.0093
178 HYPOTHERMIA 94 0.0093
179 BLOOD PRESSURE ABNORMAL 183 0.0092
180 DYSTONIA 178 0.0092
181 AFFECTIVE DISORDER 72 0.0091
182 HYPERVENTILATION 53 0.0091
183 TYPE 1 DIABETES MELLITUS 55 0.0091
184 NEUROLOGICAL SYMPTOM 52 0.0091
185 PRODUCT ADMINISTRATION INTERRUPTED 71 0.0090
186 BLOOD PRESSURE SYSTOLIC INCREASED 176 0.0090
187 DIVERTICULUM 64 0.0090
188 PERIPHERAL VASCULAR DISORDER 46 0.0089
189 JOINT DISLOCATION 94 0.0089
190 BRAIN INJURY 89 0.0089
191 EXPOSURE DURING PREGNANCY 551 0.0089
192 VASCULAR DEVICE INFECTION 40 0.0088
193 NO THERAPEUTIC RESPONSE 107 0.0088
194 SPINAL OSTEOARTHRITIS 76 0.0086
195 RENAL FAILURE ACUTE 366 0.0086
196 RALES 50 0.0086
197 TYPE 2 DIABETES MELLITUS 288 0.0085
198 DRUG WITHDRAWAL SYNDROME 748 0.0085
199 AGITATION 624 0.0085
200 ATELECTASIS 82 0.0085
201 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 81 0.0085
202 MUSCLE SPASTICITY 104 0.0085
203 FLUID OVERLOAD 123 0.0084
204 INTERVERTEBRAL DISC DEGENERATION 78 0.0084
205 LYMPHOEDEMA 58 0.0084
206 INFUSION RELATED REACTION 554 0.0083
207 APPLICATION SITE PAIN 184 0.0083
208 RETCHING 178 0.0083
209 PULMONARY CONGESTION 110 0.0083
210 LETHARGY 480 0.0083
211 SKIN ATROPHY 48 0.0083
212 HYPERKALAEMIA 292 0.0083
213 PERITONITIS BACTERIAL 84 0.0083
214 TRICUSPID VALVE INCOMPETENCE 66 0.0083
215 SPINAL COLUMN STENOSIS 39 0.0082
216 APPLICATION SITE REACTION 58 0.0082
217 HYPOTENSION 1654 0.0082
218 BLOOD PRESSURE DIASTOLIC INCREASED 38 0.0082
219 SEROTONIN SYNDROME 157 0.0082
220 ARTERIOSCLEROSIS CORONARY ARTERY 54 0.0081
221 PURPURA 72 0.0081
222 URINE OUTPUT DECREASED 71 0.0081
223 HEART RATE DECREASED 284 0.0081
224 DISSOCIATION 62 0.0081
225 SCOLIOSIS 50 0.0081
226 ENTEROCOCCAL INFECTION 39 0.0081
227 ABNORMAL BEHAVIOUR 319 0.0080
228 ELECTROCARDIOGRAM ABNORMAL 63 0.0080
229 PROTEIN URINE PRESENT 40 0.0080
230 AUTISM SPECTRUM DISORDER 44 0.0080
231 HAEMODIALYSIS 67 0.0080
232 CARDIAC MURMUR 69 0.0080
233 MULTIPLE INJURIES 50 0.0079
234 STRESS CARDIOMYOPATHY 46 0.0079
235 FAECAL INCONTINENCE 38 0.0079
236 STREPTOCOCCAL INFECTION 44 0.0079
237 BLOOD POTASSIUM INCREASED 128 0.0079
238 FEELING OF BODY TEMPERATURE CHANGE 46 0.0078
239 MYOCLONUS 93 0.0078
240 INTENTIONAL PRODUCT MISUSE 680 0.0078
241 OBSESSIVE-COMPULSIVE DISORDER 62 0.0077
242 ACIDOSIS 59 0.0077
243 FAILURE TO THRIVE 40 0.0077
244 AKATHISIA 105 0.0077
245 BIPOLAR DISORDER 83 0.0076
246 DIALYSIS 108 0.0076
247 ACUTE MYOCARDIAL INFARCTION 224 0.0076
248 DECREASED IMMUNE RESPONSIVENESS 74 0.0075
249 BLOOD UREA INCREASED 126 0.0075
250 CARDIAC ARREST 619 0.0075
251 ASPIRATION 82 0.0075
252 CARDIOMYOPATHY 110 0.0074
253 DELIRIUM 256 0.0074
254 DRUG ABUSER 45 0.0073
255 DYSKINESIA 297 0.0073
256 LUNG INFILTRATION 64 0.0072
257 THERAPY NON-RESPONDER 325 0.0072
258 FIBROMYALGIA 175 0.0072
259 BLOOD MAGNESIUM DECREASED 62 0.0072
260 DECREASED ACTIVITY 77 0.0071
261 ACUTE RESPIRATORY FAILURE 137 0.0071
262 HIATUS HERNIA 92 0.0071
263 TOXICITY TO VARIOUS AGENTS 1198 0.0071
264 INGUINAL HERNIA 43 0.0071
265 INADEQUATE ANALGESIA 60 0.0071
266 DRUG TOXICITY 96 0.0070
267 GOUT 126 0.0070
268 ECCHYMOSIS 48 0.0070
269 ASTHMA 787 0.0070
270 BLOOD PRESSURE DECREASED 462 0.0069
271 BLOOD SODIUM DECREASED 131 0.0069
272 ELECTROCARDIOGRAM QT PROLONGED 250 0.0069
273 FAECALOMA 38 0.0069
274 HYPOPHAGIA 177 0.0069
275 MEDICAL DEVICE COMPLICATION 51 0.0069
276 MITRAL VALVE INCOMPETENCE 78 0.0069
277 REFUSAL OF TREATMENT BY PATIENT 45 0.0069
278 PULMONARY HYPERTENSION 143 0.0069
279 HALLUCINATION, AUDITORY 109 0.0069
280 BLOOD TRIGLYCERIDES INCREASED 121 0.0068
281 HYPOXIA 241 0.0068
282 DIZZINESS POSTURAL 66 0.0068
283 FEAR 182 0.0068
284 AFFECT LABILITY 65 0.0067
285 OEDEMA PERIPHERAL 821 0.0067
286 TRANSIENT ISCHAEMIC ATTACK 227 0.0067
287 EXTRAPYRAMIDAL DISORDER 167 0.0067
288 DEPRESSED LEVEL OF CONSCIOUSNESS 266 0.0067
289 RESTLESSNESS 245 0.0067
290 BLOOD CREATININE INCREASED 437 0.0067
291 URINARY INCONTINENCE 198 0.0067
292 DEVICE PHYSICAL PROPERTY ISSUE 51 0.0067
293 PULMONARY OEDEMA 298 0.0066
294 MULTI-ORGAN FAILURE 115 0.0066
295 CARDIAC VALVE DISEASE 38 0.0066
296 LOWER GASTROINTESTINAL HAEMORRHAGE 49 0.0066
297 MALNUTRITION 74 0.0066
298 MYOCARDIAL ISCHAEMIA 75 0.0066
299 MANIA 108 0.0066
300 SOMNAMBULISM 43 0.0065
301 HYPERTHERMIA 50 0.0065
302 ELECTROLYTE IMBALANCE 76 0.0065
303 ANGER 221 0.0065
304 RESPIRATORY DISTRESS 180 0.0065
305 CONSTIPATION 1421 0.0065
306 SUBSTANCE ABUSE 53 0.0065
307 DRY MOUTH 528 0.0065
308 INCOHERENT 42 0.0065
309 HYPERSOMNIA 186 0.0065
310 POLYURIA 53 0.0065
311 PRODUCT PRESCRIBING ERROR 154 0.0065
312 ANGINA UNSTABLE 42 0.0065
313 HAEMORRHOIDS 125 0.0064
314 GASTROOESOPHAGEAL REFLUX DISEASE 514 0.0064
315 BLOOD PRESSURE DIASTOLIC DECREASED 47 0.0064
316 ATRIOVENTRICULAR BLOCK 49 0.0063
317 RESPIRATORY FAILURE 461 0.0063
318 CELLULITIS 318 0.0063
319 RENAL DISORDER 294 0.0063
320 MAJOR DEPRESSION 46 0.0063
321 SEASONAL ALLERGY 89 0.0063
322 GENERALISED TONIC-CLONIC SEIZURE 104 0.0063
323 ILEUS 78 0.0063
324 PSYCHOLOGICAL TRAUMA 54 0.0063
325 SOMNOLENCE 1255 0.0062
326 BACK PAIN 1445 0.0062
327 LEUKOCYTOSIS 112 0.0062
328 COAGULOPATHY 103 0.0062
329 ACUTE CORONARY SYNDROME 51 0.0062
330 INCONTINENCE 65 0.0061
331 DENTAL CARIES 68 0.0061
332 IRRITABILITY 369 0.0061
333 CARDIOGENIC SHOCK 88 0.0061
334 HYPOKALAEMIA 283 0.0061
335 CHOLECYSTITIS 73 0.0061
336 OEDEMA 331 0.0061
337 DIABETES MELLITUS INADEQUATE CONTROL 108 0.0061
338 GASTROENTERITIS VIRAL 110 0.0061
339 THERAPY PARTIAL RESPONDER 95 0.0061
340 COLITIS ISCHAEMIC 41 0.0061
341 HAEMATOCRIT DECREASED 120 0.0060
342 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 332 0.0060
343 SEIZURE 698 0.0060
344 ANXIETY 1714 0.0060
345 RHEUMATOID ARTHRITIS 683 0.0060
346 JOINT SWELLING 726 0.0060
347 MYDRIASIS 77 0.0060
348 DRUG INTERACTION 951 0.0060
349 TARDIVE DYSKINESIA 169 0.0060
350 TACHYCARDIA 531 0.0060
351 PARANOIA 103 0.0060
352 ORTHOSTATIC HYPOTENSION 104 0.0060
353 RHABDOMYOLYSIS 249 0.0060
354 RESPIRATORY RATE INCREASED 53 0.0060
355 CRYING 216 0.0059
356 PRESYNCOPE 144 0.0059
357 INJURY 416 0.0059
358 ATRIAL FLUTTER 47 0.0059
359 EXTRASYSTOLES 41 0.0059
360 TRANSPLANT REJECTION 47 0.0059
361 TORSADE DE POINTES 46 0.0059
362 OXYGEN SATURATION DECREASED 329 0.0058
363 GRAND MAL CONVULSION 54 0.0058
364 HAIR DISORDER 48 0.0058
365 GASTRITIS 153 0.0058
366 COORDINATION ABNORMAL 81 0.0058
367 PROTEINURIA 110 0.0058
368 MIDDLE INSOMNIA 108 0.0058
369 HAEMODYNAMIC INSTABILITY 44 0.0058
370 DECUBITUS ULCER 47 0.0058
371 AUTOIMMUNE DISORDER 56 0.0057
372 HEPATIC STEATOSIS 107 0.0057
373 HYDRONEPHROSIS 43 0.0057
374 PRODUCT USE ISSUE 1076 0.0057
375 SPINAL PAIN 67 0.0057
376 HYPERGLYCAEMIA 208 0.0057
377 TREATMENT NONCOMPLIANCE 312 0.0057
378 STAPHYLOCOCCAL INFECTION 188 0.0057
379 HYPOGLYCAEMIA 276 0.0057
380 BLOOD POTASSIUM DECREASED 171 0.0057
381 CONVULSION 325 0.0057
382 INTENTIONAL OVERDOSE 364 0.0057
383 BLOOD ALBUMIN DECREASED 45 0.0057
384 SCAR 97 0.0057
385 IMPAIRED WORK ABILITY 121 0.0057
386 ACCIDENTAL OVERDOSE 207 0.0057
387 INITIAL INSOMNIA 58 0.0056
388 SCIATICA 90 0.0056
389 OVERDOSE 1216 0.0056
390 OSTEOMYELITIS 102 0.0056
391 HEART RATE INCREASED 558 0.0056
392 GLOMERULAR FILTRATION RATE DECREASED 69 0.0056
393 PAIN IN JAW 159 0.0056
394 HYPERSENSITIVITY 1039 0.0056
395 WOUND INFECTION 61 0.0056
396 JOINT STIFFNESS 146 0.0056
397 HALLUCINATION 419 0.0056
398 ANAL INCONTINENCE 50 0.0056
399 TREATMENT FAILURE 460 0.0055
400 DRUG INTOLERANCE 534 0.0055
401 EMOTIONAL DISORDER 170 0.0055
402 CHEST PAIN 1019 0.0055
403 DRUG LEVEL INCREASED 91 0.0055
404 CYSTITIS 174 0.0055
405 DEVICE RELATED INFECTION 84 0.0055
406 DISTURBANCE IN ATTENTION 294 0.0054
407 PERICARDIAL EFFUSION 126 0.0054
408 HALLUCINATION, VISUAL 115 0.0054
409 FLANK PAIN 51 0.0054
410 PAROSMIA 41 0.0054
411 HAEMATURIA 186 0.0054
412 OSTEOARTHRITIS 230 0.0054
413 WRONG TECHNIQUE IN DRUG USAGE PROCESS 197 0.0054
414 SINUS TACHYCARDIA 77 0.0054
415 RED BLOOD CELL SEDIMENTATION RATE INCREASED 60 0.0054
416 DYSARTHRIA 204 0.0054
417 IRON DEFICIENCY ANAEMIA 50 0.0054
418 GENERALISED OEDEMA 67 0.0054
419 HYPOALBUMINAEMIA 42 0.0054
420 SPEECH DISORDER 283 0.0054
421 CORONARY ARTERY OCCLUSION 74 0.0054
422 MOOD SWINGS 172 0.0054
423 OBSTRUCTIVE AIRWAYS DISORDER 60 0.0054
424 COLD SWEAT 95 0.0054
425 HAEMORRHAGIC STROKE 42 0.0054
426 TREMOR 892 0.0054
427 KIDNEY INFECTION 105 0.0053
428 OSTEOPENIA 81 0.0053
429 VITAMIN D DEFICIENCY 52 0.0053
430 BODY HEIGHT DECREASED 57 0.0053
431 INSOMNIA 1415 0.0053
432 VENTRICULAR FIBRILLATION 59 0.0053
433 HYPOKINESIA 77 0.0053
434 SALIVARY HYPERSECRETION 53 0.0053
435 PSYCHIATRIC SYMPTOM 39 0.0053
436 RESTLESS LEGS SYNDROME 96 0.0053
437 DIABETES MELLITUS 402 0.0053
438 RENAL IMPAIRMENT 442 0.0053
439 AORTIC ANEURYSM 40 0.0053
440 MUSCLE TIGHTNESS 85 0.0052
441 IRRITABLE BOWEL SYNDROME 112 0.0052
442 STEVENS-JOHNSON SYNDROME 116 0.0052
443 SENSORY LOSS 42 0.0052
444 SUICIDAL IDEATION 477 0.0052
445 PAIN 3197 0.0052
446 VENTRICULAR EXTRASYSTOLES 54 0.0052
447 LOSS OF CONSCIOUSNESS 666 0.0052
448 PRODUCT SUBSTITUTION ISSUE 299 0.0052
449 INCREASED APPETITE 99 0.0052
450 MUSCLE TWITCHING 119 0.0052
451 BODY TEMPERATURE INCREASED 105 0.0051
452 HAIR COLOUR CHANGES 64 0.0051
453 GYNAECOMASTIA 159 0.0051
454 DEHYDRATION 685 0.0051
455 ENCEPHALOPATHY 126 0.0051
456 SPLENOMEGALY 60 0.0051
457 ANOREXIA 66 0.0051
458 CEREBROVASCULAR ACCIDENT 865 0.0051
459 BACK DISORDER 83 0.0051
460 IMPAIRED DRIVING ABILITY 58 0.0051
461 DISORIENTATION 202 0.0051
462 CANDIDA INFECTION 86 0.0051
463 GASTROINTESTINAL HAEMORRHAGE 425 0.0051
464 QUALITY OF LIFE DECREASED 68 0.0051
465 NECK PAIN 283 0.0051
466 THROMBOCYTOPENIA 566 0.0051
467 TRANSFUSION 53 0.0051
468 BLOOD CHOLESTEROL INCREASED 235 0.0050
469 VITAMIN D DECREASED 43 0.0050
470 HAEMORRHAGE INTRACRANIAL 75 0.0050
471 DEVICE INFORMATION OUTPUT ISSUE 39 0.0050
472 TOOTH ABSCESS 51 0.0050
473 PHARYNGEAL OEDEMA 77 0.0050
474 WEIGHT INCREASED 1120 0.0050
475 SYNCOPE 500 0.0050
476 DYSPNOEA EXERTIONAL 188 0.0050
477 EAR PAIN 97 0.0050
478 BODY TEMPERATURE DECREASED 49 0.0050
479 HYPOAESTHESIA 745 0.0050
480 NEURALGIA 121 0.0050
481 MUSCULAR WEAKNESS 562 0.0049
482 PANIC ATTACK 180 0.0049
483 GALLBLADDER DISORDER 88 0.0049
484 SKIN DISORDER 164 0.0049
485 HEART RATE IRREGULAR 111 0.0049
486 MEDICATION ERROR 273 0.0049
487 ANKLE FRACTURE 76 0.0049
488 SLEEP DISORDER 346 0.0049
489 NERVOUSNESS 256 0.0049
490 HEADACHE 3070 0.0049
491 LACERATION 46 0.0049
492 INCREASED TENDENCY TO BRUISE 45 0.0049
493 URINARY TRACT INFECTION 832 0.0049
494 CONTUSION 469 0.0049
495 DYSURIA 179 0.0049
496 SPINAL DISORDER 46 0.0049
497 PANCREATITIS ACUTE 109 0.0048
498 METABOLIC ACIDOSIS 155 0.0048
499 WEIGHT DECREASED 1349 0.0048
500 DEVICE DISLOCATION 210 0.0048
501 NODULE 63 0.0048
502 DEFORMITY 45 0.0048
503 SUBARACHNOID HAEMORRHAGE 49 0.0048
504 EAR INFECTION 128 0.0048
505 ROAD TRAFFIC ACCIDENT 201 0.0048
506 DEPRESSION 1093 0.0048
507 MOOD ALTERED 131 0.0048
508 ATAXIA 57 0.0048
509 BACTERAEMIA 57 0.0048
510 EYE HAEMORRHAGE 64 0.0048
511 ORAL PAIN 107 0.0048
512 HELICOBACTER INFECTION 49 0.0048
513 PULMONARY MASS 71 0.0048
514 HYPONATRAEMIA 268 0.0048
515 IMPAIRED HEALING 156 0.0047
516 ACTIVITIES OF DAILY LIVING IMPAIRED 94 0.0047
517 COMA 226 0.0047
518 DRUG ADMINISTRATION ERROR 145 0.0047
519 VIRAL INFECTION 157 0.0047
520 TOOTH FRACTURE 52 0.0047
521 MUSCULOSKELETAL CHEST PAIN 73 0.0047
522 DRUG LEVEL DECREASED 48 0.0047
523 PANCREATITIS 249 0.0047
524 HAIR TEXTURE ABNORMAL 63 0.0047
525 TACHYPNOEA 64 0.0047
526 SEPSIS 524 0.0047
527 HYPOTHYROIDISM 150 0.0047
528 ACUTE RESPIRATORY DISTRESS SYNDROME 83 0.0047
529 VOMITING 2206 0.0047
530 BACK INJURY 51 0.0047
531 DRUG ABUSE 389 0.0047
532 HEMIPARESIS 79 0.0047
533 SKIN DISCOLOURATION 214 0.0047
534 MASS 65 0.0046
535 DRUG USE DISORDER 39 0.0046
536 VASCULITIS 54 0.0046
537 FEEDING DISORDER 94 0.0046
538 ORAL CANDIDIASIS 61 0.0046
539 DRUG PRESCRIBING ERROR 89 0.0046
540 ATRIAL FIBRILLATION 451 0.0046
541 DRUG EFFECT DECREASED 249 0.0046
542 SENSORY DISTURBANCE 74 0.0046
543 ORAL HERPES 90 0.0046
544 BONE DISORDER 84 0.0046
545 ROTATOR CUFF SYNDROME 59 0.0046
546 FACIAL PAIN 41 0.0046
547 GASTROENTERITIS 67 0.0046
548 THIRST 82 0.0046
549 SUICIDE ATTEMPT 278 0.0046
550 POST PROCEDURAL COMPLICATION 88 0.0046
551 HEPATOMEGALY 45 0.0046
552 INTERVERTEBRAL DISC PROTRUSION 100 0.0046
553 ANGINA PECTORIS 131 0.0046
554 CONFUSIONAL STATE 738 0.0046
555 PNEUMONIA ASPIRATION 114 0.0046
556 EATING DISORDER 97 0.0046
557 PULMONARY ARTERIAL HYPERTENSION 66 0.0046
558 HAEMATOMA 118 0.0045
559 TOOTH INFECTION 60 0.0045
560 VENTRICULAR TACHYCARDIA 75 0.0045
561 ABASIA 112 0.0045
562 MUSCULOSKELETAL PAIN 237 0.0045
563 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 236 0.0045
564 MUSCLE RIGIDITY 54 0.0045
565 PRODUCT QUALITY ISSUE 612 0.0045
566 DECREASED APPETITE 1045 0.0045
567 NERVE INJURY 50 0.0045
568 EXOSTOSIS 41 0.0045
569 WRONG DRUG ADMINISTERED 40 0.0045
570 MENTAL DISORDER 195 0.0045
571 APHASIA 135 0.0045
572 BLOOD IRON DECREASED 53 0.0045
573 TEMPERATURE INTOLERANCE 46 0.0045
574 DRUG ADMINISTERED AT INAPPROPRIATE SITE 47 0.0045
575 INTENTIONAL SELF-INJURY 90 0.0045
576 BLOOD CALCIUM DECREASED 50 0.0044
577 EJECTION FRACTION DECREASED 69 0.0044
578 BLOOD URINE PRESENT 84 0.0044
579 EMOTIONAL DISTRESS 535 0.0044
580 INTENTIONAL DRUG MISUSE 92 0.0044
581 MADAROSIS 51 0.0044
582 SMALL INTESTINAL OBSTRUCTION 54 0.0044
583 FEELING COLD 122 0.0044
584 FOOT FRACTURE 83 0.0044
585 URINARY RETENTION 146 0.0044
586 DYSPHAGIA 415 0.0044
587 FALL 1451 0.0044
588 SWOLLEN TONGUE 136 0.0043
589 MUCOSAL INFLAMMATION 114 0.0043
590 PERITONITIS 90 0.0043
591 BLISTER 244 0.0043
592 PSYCHOTIC DISORDER 128 0.0043
593 DYSPNOEA 2451 0.0043
594 HEAD INJURY 137 0.0043
595 PALPITATIONS 507 0.0043
596 GROIN PAIN 38 0.0043
597 SKIN LACERATION 47 0.0043
598 PLEURAL EFFUSION 263 0.0043
599 LOWER LIMB FRACTURE 83 0.0043
600 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 74 0.0043
601 HIP ARTHROPLASTY 66 0.0043
602 LIMB INJURY 117 0.0043
603 BURNING SENSATION 302 0.0043
604 OESOPHAGITIS 47 0.0043
605 MIGRAINE 410 0.0043
606 BACTERIAL INFECTION 80 0.0043
607 ERYTHEMA 880 0.0043
608 DYSPEPSIA 421 0.0043
609 STOMATITIS 259 0.0043
610 INFECTION 618 0.0043
611 MOVEMENT DISORDER 137 0.0043
612 HAEMOGLOBIN DECREASED 438 0.0043
613 LOCALISED INFECTION 103 0.0043
614 SKIN ULCER 110 0.0043
615 DYSSTASIA 124 0.0042
616 BONE DENSITY DECREASED 133 0.0042
617 PERIPHERAL SWELLING 653 0.0042
618 HYPOMAGNESAEMIA 59 0.0042
619 SKIN LESION 116 0.0042
620 BRONCHITIS 313 0.0042
621 AMNESIA 275 0.0042
622 PALLOR 115 0.0042
623 VISION BLURRED 579 0.0042
624 RESPIRATORY DISORDER 126 0.0042
625 INTERNATIONAL NORMALISED RATIO INCREASED 120 0.0042
626 BLOOD GLUCOSE FLUCTUATION 46 0.0042
627 TOOTH LOSS 87 0.0042
628 ACCIDENT 50 0.0042
629 LOCAL SWELLING 73 0.0042
630 MUSCULOSKELETAL DISCOMFORT 72 0.0042
631 MYOCARDIAL INFARCTION 728 0.0042
632 FEELING ABNORMAL 999 0.0042
633 MOBILITY DECREASED 298 0.0041
634 LIGAMENT SPRAIN 41 0.0041
635 FEELING JITTERY 79 0.0041
636 HAEMATEMESIS 105 0.0041
637 ABDOMINAL PAIN 961 0.0041
638 EPISTAXIS 309 0.0041
639 THERAPEUTIC RESPONSE DECREASED 250 0.0041
640 PETECHIAE 43 0.0041
641 DELUSION 64 0.0041
642 FULL BLOOD COUNT DECREASED 83 0.0041
643 WOUND 115 0.0041
644 NEUROTOXICITY 72 0.0041
645 NIGHTMARE 142 0.0041
646 CATARACT 244 0.0041
647 DIZZINESS 2043 0.0041
648 CHOLELITHIASIS 134 0.0041
649 ANAEMIA 778 0.0041
650 GAIT DISTURBANCE 780 0.0041
651 UNEVALUABLE EVENT 308 0.0041
652 PAIN IN EXTREMITY 1198 0.0041
653 UNINTENTIONAL MEDICAL DEVICE REMOVAL 47 0.0041
654 FATIGUE 3163 0.0041
655 PNEUMONIA 1313 0.0041
656 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
657 ASTHENIA 1524 0.0040
658 WHEEZING 240 0.0040
659 PYREXIA 1400 0.0040
660 SINUS DISORDER 80 0.0040
661 BRAIN OEDEMA 51 0.0040
662 NOCTURIA 49 0.0040
663 TINNITUS 185 0.0040
664 UPPER LIMB FRACTURE 80 0.0040
665 CYANOSIS 63 0.0040
666 PERIPHERAL COLDNESS 55 0.0040
667 MENTAL IMPAIRMENT 97 0.0040
668 PRODUCT AVAILABILITY ISSUE 91 0.0040
669 OSTEOPOROSIS 164 0.0040
670 ABDOMINAL DISTENSION 416 0.0040
671 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0040
672 REBOUND EFFECT 45 0.0040
673 POLLAKIURIA 166 0.0040
674 RECTAL HAEMORRHAGE 171 0.0040
675 NAUSEA 3149 0.0040
676 BLOOD GLUCOSE DECREASED 191 0.0040
677 THINKING ABNORMAL 74 0.0040
678 ARRHYTHMIA 188 0.0040
679 CHILLS 465 0.0040
680 THERAPY CHANGE 39 0.0040
681 WHITE BLOOD CELL COUNT INCREASED 152 0.0040
682 GINGIVAL BLEEDING 54 0.0040
683 NEUROPATHY PERIPHERAL 376 0.0039
684 PRODUCT PRESCRIBING ISSUE 86 0.0039
685 SCAB 45 0.0039
686 JOINT INJURY 84 0.0039
687 MUSCLE SPASMS 721 0.0039
688 TOOTHACHE 71 0.0039
689 PARALYSIS 56 0.0039
690 BONE PAIN 228 0.0039
691 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100 0.0039
692 SWELLING 363 0.0039
693 HAEMOPTYSIS 108 0.0039
694 DRUG DISPENSING ERROR 59 0.0039
695 CARPAL TUNNEL SYNDROME 54 0.0039
696 BALANCE DISORDER 333 0.0038
697 MOUTH ULCERATION 81 0.0038
698 LYMPHADENOPATHY 136 0.0038
699 FEELING HOT 235 0.0038
700 DIABETIC KETOACIDOSIS 92 0.0038
701 BLINDNESS UNILATERAL 54 0.0038
702 EUPHORIC MOOD 39 0.0038
703 HYPERCALCAEMIA 47 0.0038
704 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 39 0.0038
705 SINUSITIS 389 0.0038
706 BRAIN FOG 59 0.0038
707 ABDOMINAL PAIN UPPER 774 0.0038
708 NIGHT SWEATS 121 0.0038
709 DEPRESSED MOOD 198 0.0037
710 DIARRHOEA 2403 0.0037
711 COMPLICATION ASSOCIATED WITH DEVICE 54 0.0037
712 BLOOD CREATINE PHOSPHOKINASE INCREASED 107 0.0037
713 BRONCHOSPASM 53 0.0037
714 GAIT INABILITY 124 0.0037
715 SCRATCH 39 0.0037
716 DIVERTICULITIS 102 0.0037
717 CHROMATURIA 83 0.0037
718 COUGH 1030 0.0037
719 LIVER INJURY 90 0.0037
720 PHARMACEUTICAL PRODUCT COMPLAINT 95 0.0037
721 ULCER 58 0.0036
722 GASTROINTESTINAL PAIN 40 0.0036
723 MUSCLE ATROPHY 46 0.0036
724 DIPLOPIA 94 0.0036
725 SHOCK 83 0.0036
726 NASAL CONGESTION 212 0.0036
727 OFF LABEL USE 3152 0.0036
728 DEVICE LEAKAGE 156 0.0036
729 INTERNAL HAEMORRHAGE 41 0.0036
730 RESPIRATORY TRACT CONGESTION 57 0.0036
731 WRIST FRACTURE 43 0.0036
732 FLUSHING 364 0.0036
733 HERNIA 69 0.0036
734 SWELLING FACE 232 0.0036
735 CHEST DISCOMFORT 364 0.0036
736 ABDOMINAL DISCOMFORT 593 0.0035
737 RED BLOOD CELL COUNT DECREASED 101 0.0035
738 PLATELET COUNT INCREASED 46 0.0035
739 LACTIC ACIDOSIS 114 0.0035
740 LIP SWELLING 117 0.0035
741 BLOOD ALKALINE PHOSPHATASE INCREASED 87 0.0035
742 RIB FRACTURE 72 0.0035
743 SEPTIC SHOCK 151 0.0035
744 BLOOD GLUCOSE ABNORMAL 64 0.0035
745 ORAL DISCOMFORT 48 0.0035
746 HUNGER 48 0.0034
747 DYSPHONIA 201 0.0034
748 PARAESTHESIA 540 0.0034
749 BLOOD COUNT ABNORMAL 52 0.0034
750 PRODUCT PHYSICAL ISSUE 69 0.0034
751 ALTERED STATE OF CONSCIOUSNESS 74 0.0034
752 CHOLECYSTECTOMY 39 0.0034
753 DEVICE ISSUE 306 0.0034
754 ASCITES 100 0.0034
755 MEMORY IMPAIRMENT 467 0.0034
756 CONDITION AGGRAVATED 1033 0.0034
757 DERMATITIS 71 0.0034
758 PSORIASIS 442 0.0034
759 CARDIAC DISORDER 316 0.0034
760 HERPES ZOSTER 194 0.0034
761 PRODUCT ADMINISTRATION ERROR 68 0.0034
762 THROAT TIGHTNESS 90 0.0033
763 DEVICE MALFUNCTION 233 0.0033
764 EYE DISORDER 109 0.0033
765 RASH 1443 0.0033
766 THYROID DISORDER 51 0.0033
767 LUNG DISORDER 162 0.0033
768 CONJUNCTIVITIS 61 0.0033
769 DISABILITY 65 0.0033
770 BEDRIDDEN 43 0.0033
771 LIMB DISCOMFORT 101 0.0033
772 INFLUENZA 364 0.0033
773 HYPOAESTHESIA ORAL 49 0.0032
774 GENERAL PHYSICAL HEALTH DETERIORATION 376 0.0032
775 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 156 0.0032
776 CARDIOVASCULAR DISORDER 82 0.0032
777 DRUG INEFFECTIVE 4256 0.0032
778 CHOKING 63 0.0032
779 GLYCOSYLATED HAEMOGLOBIN INCREASED 81 0.0032
780 MYALGIA 543 0.0032
781 PHOTOPHOBIA 60 0.0032
782 MUSCULOSKELETAL STIFFNESS 278 0.0032
783 GLOSSODYNIA 71 0.0032
784 INJECTION SITE INDURATION 41 0.0032
785 OROPHARYNGEAL PAIN 292 0.0032
786 PHOTOSENSITIVITY REACTION 52 0.0031
787 BLOOD GLUCOSE INCREASED 592 0.0031
788 CLOSTRIDIUM DIFFICILE INFECTION 68 0.0031
789 PRODUCT PREPARATION ERROR 64 0.0031
790 ABNORMAL DREAMS 86 0.0031
791 SINUS CONGESTION 42 0.0031
792 MALAISE 1362 0.0031
793 HOT FLUSH 234 0.0031
794 INTESTINAL OBSTRUCTION 117 0.0031
795 SPINAL FRACTURE 62 0.0031
796 CARDIAC FAILURE 248 0.0031
797 KNEE ARTHROPLASTY 65 0.0031
798 FLATULENCE 175 0.0031
799 DEEP VEIN THROMBOSIS 200 0.0031
800 SUBDURAL HAEMATOMA 44 0.0031
801 CEREBRAL HAEMORRHAGE 110 0.0031
802 RHINORRHOEA 198 0.0031
803 PRURITUS GENERALISED 66 0.0030
804 RASH GENERALISED 79 0.0030
805 NERVOUS SYSTEM DISORDER 95 0.0030
806 VISUAL ACUITY REDUCED 101 0.0030
807 ILLNESS 313 0.0030
808 INFLAMMATION 156 0.0030
809 INCORRECT DRUG ADMINISTRATION DURATION 85 0.0030
810 THROMBOSIS 243 0.0030
811 DRUG DOSE OMISSION 499 0.0030
812 HAEMATOCHEZIA 166 0.0030
813 ANAPHYLACTIC REACTION 166 0.0030
814 DEVICE USE ERROR 104 0.0030
815 HIP FRACTURE 96 0.0030
816 DYSGEUSIA 220 0.0030
817 GLAUCOMA 57 0.0030
818 LABORATORY TEST ABNORMAL 87 0.0029
819 INTENTIONAL DOSE OMISSION 84 0.0029
820 NEPHROLITHIASIS 135 0.0029
821 INSURANCE ISSUE 45 0.0029
822 THERAPEUTIC RESPONSE UNEXPECTED 132 0.0029
823 ARTHRALGIA 1222 0.0029
824 LEUKOPENIA 147 0.0029
825 DEVICE ADHESION ISSUE 45 0.0029
826 DRUG DEPENDENCE 471 0.0029
827 MULTIPLE FRACTURES 48 0.0029
828 DRUG WITHDRAWAL SYNDROME NEONATAL 43 0.0029
829 PNEUMOTHORAX 46 0.0029
830 ASPARTATE AMINOTRANSFERASE INCREASED 154 0.0029
831 UNDERDOSE 211 0.0029
832 LYMPHOCYTE COUNT DECREASED 51 0.0029
833 TOOTH DISORDER 64 0.0029
834 INTENTIONAL PRODUCT USE ISSUE 252 0.0029
835 EYE SWELLING 107 0.0029
836 VERTIGO 175 0.0029
837 SNEEZING 64 0.0029
838 HYPOCALCAEMIA 54 0.0029
839 THROAT IRRITATION 128 0.0028
840 PARAESTHESIA ORAL 41 0.0028
841 MULTIPLE ORGAN DYSFUNCTION SYNDROME 80 0.0028
842 HEPATIC CIRRHOSIS 53 0.0028
843 PRURITUS 1082 0.0028
844 ANGIOEDEMA 124 0.0028
845 URTICARIA 469 0.0028
846 BLINDNESS 114 0.0028
847 PRODUCT USE COMPLAINT 44 0.0028
848 DEMENTIA 78 0.0028
849 PLATELET COUNT DECREASED 295 0.0028
850 PRESCRIBED UNDERDOSE 55 0.0028
851 ARTHRITIS 216 0.0027
852 ISCHAEMIC STROKE 49 0.0027
853 FAECES DISCOLOURED 59 0.0027
854 COGNITIVE DISORDER 127 0.0027
855 ADVERSE DRUG REACTION 244 0.0027
856 GASTROINTESTINAL DISORDER 243 0.0027
857 DISCOMFORT 165 0.0027
858 ALOPECIA 529 0.0027
859 GASTRIC ULCER 51 0.0027
860 GASTRIC DISORDER 92 0.0027
861 PRODUCT USE IN UNAPPROVED INDICATION 661 0.0027
862 NASOPHARYNGITIS 489 0.0027
863 DRUG EFFECT INCOMPLETE 96 0.0026
864 RASH PAPULAR 59 0.0026
865 SKIN HAEMORRHAGE 39 0.0026
866 INJECTION SITE MASS 97 0.0026
867 FUNGAL INFECTION 87 0.0026
868 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 528 0.0026
869 RASH MACULAR 91 0.0026
870 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 44 0.0026
871 ALANINE AMINOTRANSFERASE INCREASED 158 0.0026
872 EYE PAIN 145 0.0026
873 RASH PRURITIC 139 0.0026
874 PRODUCTIVE COUGH 122 0.0026
875 THERAPY CESSATION 131 0.0025
876 HEAD DISCOMFORT 45 0.0025
877 COLITIS 96 0.0025
878 HYPOACUSIS 109 0.0025
879 INFLUENZA LIKE ILLNESS 208 0.0025
880 VISUAL IMPAIRMENT 313 0.0025
881 MUSCULOSKELETAL DISORDER 48 0.0025
882 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 179 0.0025
883 LIVER FUNCTION TEST INCREASED 54 0.0025
884 PULMONARY EMBOLISM 239 0.0025
885 ABSCESS 40 0.0025
886 BASAL CELL CARCINOMA 39 0.0025
887 PRODUCT DISPENSING ERROR 54 0.0025
888 PRODUCT DOSE OMISSION 161 0.0025
889 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
890 PANCYTOPENIA 137 0.0024
891 HAEMORRHAGE 254 0.0024
892 ERUCTATION 47 0.0024
893 DRY EYE 121 0.0024
894 RESPIRATORY TRACT INFECTION 63 0.0024
895 LIVER FUNCTION TEST ABNORMAL 70 0.0024
896 HOSPITALISATION 367 0.0024
897 HEPATIC FAILURE 72 0.0024
898 LOWER RESPIRATORY TRACT INFECTION 108 0.0024
899 TASTE DISORDER 48 0.0024
900 ARTHROPATHY 131 0.0024
901 PRODUCT DOSE OMISSION ISSUE 690 0.0023
902 ADVERSE EVENT 213 0.0023
903 PROCEDURAL PAIN 64 0.0023
904 ERECTILE DYSFUNCTION 59 0.0023
905 BLOOD BILIRUBIN INCREASED 62 0.0023
906 DEAFNESS 60 0.0023
907 ILL-DEFINED DISORDER 139 0.0023
908 SURGERY 134 0.0023
909 LACRIMATION INCREASED 69 0.0023
910 AMENORRHOEA 40 0.0023
911 PAIN OF SKIN 61 0.0023
912 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 161 0.0023
913 PELVIC PAIN 41 0.0023
914 SKIN FISSURES 44 0.0022
915 PREMATURE BABY 67 0.0022
916 FREQUENT BOWEL MOVEMENTS 60 0.0022
917 CEREBRAL INFARCTION 54 0.0022
918 AGEUSIA 55 0.0022
919 SKIN IRRITATION 100 0.0022
920 SKIN CANCER 47 0.0022
921 C-REACTIVE PROTEIN INCREASED 79 0.0022
922 FEBRILE NEUTROPENIA 144 0.0022
923 INJECTION SITE REACTION 147 0.0021
924 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 49 0.0021
925 ABDOMINAL PAIN LOWER 53 0.0021
926 WHITE BLOOD CELL COUNT DECREASED 226 0.0021
927 SYSTEMIC LUPUS ERYTHEMATOSUS 74 0.0021
928 CHOLESTASIS 40 0.0021
929 THERAPEUTIC PRODUCT EFFECT DECREASED 93 0.0021
930 EXPIRED PRODUCT ADMINISTERED 69 0.0021
931 THERAPY INTERRUPTED 146 0.0020
932 SKIN EXFOLIATION 172 0.0020
933 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 367 0.0020
934 ANAPHYLACTIC SHOCK 50 0.0019
935 JAUNDICE 52 0.0019
936 DRUG-INDUCED LIVER INJURY 60 0.0019
937 DEVICE BREAKAGE 77 0.0019
938 LIVER DISORDER 84 0.0019
939 HEPATOTOXICITY 42 0.0019
940 INCORRECT DOSE ADMINISTERED 430 0.0019
941 PRODUCT DOSE OMISSION IN ERROR 53 0.0019
942 NEEDLE ISSUE 54 0.0019
943 DEATH 1589 0.0018
944 EYE IRRITATION 104 0.0018
945 COVID-19 316 0.0018
946 PNEUMONITIS 49 0.0018
947 MATERNAL EXPOSURE DURING PREGNANCY 160 0.0018
948 THERAPEUTIC RESPONSE SHORTENED 59 0.0018
949 FOETAL EXPOSURE DURING PREGNANCY 144 0.0018
950 OCULAR HYPERAEMIA 83 0.0017
951 FEMUR FRACTURE 54 0.0017
952 SKIN BURNING SENSATION 124 0.0017
953 DRUG RESISTANCE 44 0.0017
954 EPILEPSY 52 0.0017
955 DRY SKIN 222 0.0017
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 56 0.0017
957 HEPATITIS 42 0.0016
958 LUNG NEOPLASM MALIGNANT 67 0.0016
959 VAGINAL HAEMORRHAGE 70 0.0016
960 EYE PRURITUS 54 0.0016
961 DISEASE PROGRESSION 189 0.0016
962 INCORRECT ROUTE OF DRUG ADMINISTRATION 57 0.0016
963 DISEASE RECURRENCE 75 0.0016
964 NEUTROPENIA 212 0.0016
965 EXTRA DOSE ADMINISTERED 63 0.0016
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 72 0.0015
967 INCORRECT DOSE ADMINISTERED BY DEVICE 40 0.0015
968 DEVICE DIFFICULT TO USE 98 0.0015
969 NEUTROPHIL COUNT DECREASED 60 0.0015
970 MULTIPLE SCLEROSIS 70 0.0015
971 NO ADVERSE EVENT 265 0.0015
972 INJECTION SITE PAIN 446 0.0015
973 INJECTION SITE BRUISING 112 0.0014
974 PSORIATIC ARTHROPATHY 56 0.0014
975 DERMATITIS ATOPIC 71 0.0013
976 ECZEMA 70 0.0013
977 PLASMA CELL MYELOMA 52 0.0013
978 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38 0.0013
979 NEOPLASM MALIGNANT 84 0.0013
980 INJECTION SITE HAEMORRHAGE 98 0.0012
981 INJECTION SITE PRURITUS 82 0.0012
982 INJECTION SITE SWELLING 89 0.0012
983 INJECTION SITE ERYTHEMA 143 0.0012
984 NEOPLASM PROGRESSION 39 0.0011
985 MALIGNANT NEOPLASM PROGRESSION 114 0.0011
986 MULTIPLE SCLEROSIS RELAPSE 71 0.0010
987 ACNE 77 0.0010
988 COLITIS ULCERATIVE 43 0.0010
989 ACCIDENTAL EXPOSURE TO PRODUCT 99 0.0010
990 BREAST CANCER 89 0.0010
991 INTERSTITIAL LUNG DISEASE 42 0.0009
992 DRUG DOSE OMISSION BY DEVICE 65 0.0008
993 PRODUCT STORAGE ERROR 57 0.0007